Study guide

19.5 Recognizing and Managing Substance Use Disorders

Integrated National Board Dental Examination INBDE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: INBDE Exam Structure & Test Specifications

1.1 INBDE Format, Administration, Scoring & Retesting 1.2 The Domain of Dentistry: Test Specifications, Item Formats, Patient Boxes & Dental Charts

2 Chapter 2: Foundation Knowledge — Anatomic Sciences & Development

2.1 Gross & Head/Neck Anatomy and Histology 2.2 Oral Embryology, Tooth Development & Eruption 2.3 Genetic, Congenital & Developmental Conditions

3 Chapter 3: Foundation Knowledge — Biochemistry, Physiology & Physical Sciences

3.1 Biochemistry and Systemic Physiology 3.2 Physics & Chemistry of Oral Biology: pH, Diffusion & Demineralization

4 Chapter 4: Foundation Knowledge — Pathology, Microbiology & Immunology

4.1 General & Systemic Pathology 4.2 Microbiology, Immunology, and Infection Pathogenesis

5 Chapter 5: Foundation Knowledge — Pharmacology

5.1 Dental Pharmacology, Local Anesthetics, and Analgesics 5.2 Systemic Medications and Drug Interactions in Dentistry

6 Chapter 6: Foundation Knowledge — Dental Anatomy, Occlusion & Materials

6.1 Tooth Morphology, Anatomy, and Occlusion Biomechanics 6.2 Dental Materials Science, Biomaterials, and Impression Systems

7 Chapter 7: Patient Evaluation & Data Gathering

7.1 Chief Complaint, History Taking & Information from Diverse Sources 7.2 Comprehensive Patient History, Examination, and Medical Risk Assessment 7.3 Vital Signs, ASA Physical Status & Medical Risk Stratification 7.4 Normal Findings vs Significant Deviations Requiring Management

8 Chapter 8: Diagnostic Imaging

8.1 Dental Radiology Physics, Safety, and Imaging Interpretation 8.2 Intraoral Radiographic Technique, Errors & Quality Assurance 8.3 Radiographic Interpretation of Caries, Periapical & Bone Lesions 8.4 Panoramic, CBCT & Selection Criteria for Advanced Imaging

9 Chapter 9: Diagnostic Reasoning & Systemic Assessment

9.1 Diagnostic Testing, Laboratory Values, and Medical Complexities 9.2 Predictive Diagnostic Reasoning & Selecting the Right Diagnostic Test 9.3 Oral–Systemic Interrelationships 9.4 Differential Diagnosis of Orofacial Pain

10 Chapter 10: Oral Pathology & Mucosal Disease

10.1 Benign and Malignant Oral Pathology and Biopsy Protocols 10.2 Managing Oral Mucosal and Osseous Diseases

11 Chapter 11: Treatment Planning, Prognosis & Communication

11.1 Interdisciplinary Treatment Planning Sequencing and Prognosis 11.2 Prognosis Determination & Presenting Treatment Alternatives 11.3 Informed Consent, Refusal & Patient Education 11.4 Patient Attributes, Culture, Social Background & Care Across the Lifespan 11.5 Psychological, Social & Behavioral Principles in Patient Communication 11.6 Evaluating the Outcomes of Comprehensive Dental Care

12 Chapter 12: Medical & Dental Emergencies

12.1 Dental and Medical Emergencies in the Dental Office 12.2 Recognizing and Triaging Dental Emergencies

13 Chapter 13: Caries, Operative & Esthetic Dentistry

13.1 Caries Risk Assessment, Prevention, and Operative Dentistry 13.2 Adhesive Dentistry, Composite/Amalgam Restorations, and Esthetics 13.3 Managing the Esthetic Needs of Patients

14 Chapter 14: Endodontics

14.1 Pulpal Biology, Endodontic Diagnosis, and Emergency Treatment 14.2 Endodontic Therapy, Root Canal Instrumentation, Obturation, and Surgery

15 Chapter 15: Periodontics & Implantology

15.1 Periodontal Pathogenesis, Etiology, and Disease Classification 15.2 Non-Surgical Periodontal Therapy and Maintenance Protocols 15.3 Surgical Periodontics, Mucogingival Procedures, and Regenerative Care 15.4 Dental Implants: Planning, Surgical Placement, and Restorative Options

16 Chapter 16: Prosthodontics & Laboratory Communication

16.1 Fixed Prosthodontics: Crown/Bridge Preparation, Design, and Cementation 16.2 Removable Complete Dentures: Impression, Occlusion, and Delivery 16.3 Removable Partial Dentures: Components, Design, and Frameworks 16.4 Communicating Case Design to the Dental Laboratory

17 Chapter 17: Pain Control, Anesthesia & Oral Surgery

17.1 Local Anesthetic Techniques, Complications, and Nitrous Oxide Sedation 17.2 Dentoalveolar Surgery, Tooth Extraction, and Surgical Complications 17.3 Maxillofacial Trauma, Odontogenic Infections, and Complex Surgery

18 Chapter 18: Occlusion, TMD & Orthodontics

18.1 Craniofacial Growth, Development, and Orthodontic Diagnosis/Intervention 18.2 Developmental & Acquired Occlusal Problems 18.3 Temporomandibular Disorders: Diagnosis and Management

19 Chapter 19: Pediatric, Special Care & Vulnerable Patients

19.1 Pediatric Dental Care, Behavior Guidance, and Preventive Services 19.2 Pediatric Restorative Dentistry, Pulpal Therapy, and Dental Trauma 19.3 Special Care Dentistry: Geriatric, Special Needs, and Medically Compromised Patients 19.4 Recognizing, Managing & Reporting Patient Abuse and Neglect 19.5 Recognizing and Managing Substance Use Disorders

20 Chapter 20: Practice Management, Safety Systems & Informatics

20.1 Infection Control Protocols, Sterilization, and OSHA Compliance 20.2 Radiation Safety Guidelines, Dosimetry, and ALARA Principles 20.3 Practice Business Operations, OSHA & Regulatory Compliance 20.4 Catastrophe Preparedness & Practice Continuity Planning 20.5 Managing, Coordinating & Supervising Allied Dental Personnel 20.6 Quality Assurance, Assessment and Improvement 20.7 Dental Informatics, Electronic Records & Emerging Technology 20.8 Scope of Competence, Referral & Professional Self-Assessment

21 Chapter 21: Ethics, Jurisprudence, Evidence & Public Health

21.1 ADA Ethics Code, Jurisprudence, HIPAA, and Professional Conduct 21.2 Evidence-Based Dentistry, Clinical Epidemiology, and Dental Public Health 21.3 Biostatistics, Study Design & Critical Appraisal 21.4 Community Collaboration & Systems of Oral Health Care Delivery 21.5 Emerging Trends and Social/Economic Forces in Oral Health Care 21.6 Prevention, Intervention & Patient Education Strategies

19.5 Recognizing and Managing Substance Use Disorders

Key Takeaways Explain This Topic AI

Local anesthetic containing epinephrine is contraindicated within roughly 24 hours of cocaine or methamphetamine use because of the risk of hypertensive crisis, arrhythmia, and myocardial infarction

Methamphetamine use produces rampant cervical and smooth-surface caries driven by xerostomia, bruxism, high-sugar beverage intake, and neglected hygiene

Patients taking buprenorphine or methadone for opioid use disorder should continue that therapy, and acute pain is managed with non-opioid multimodal analgesia in coordination with the treating provider

Alcohol use disorder impairs hepatic drug metabolism and coagulation, so acetaminophen dosing is reduced and bleeding risk is assessed before surgery

Prescription drug monitoring program review before prescribing a controlled substance is required in most states and is good practice everywhere

Last updated: August 2026

Recognizing and Managing Substance Use Disorders

Why this matters on the INBDE: This is a named blueprint task, and it intersects directly with pharmacology (FK8, 11%) and behavioral science and jurisprudence (FK9, 11%). Dentists are prescribers of controlled substances and are often the first clinician to see the oral consequences of substance use.

Screening

Ask about substance use as a routine, non-judgmental part of the medical history, in the same tone as questions about medications. Specific, quantified questions elicit more accurate answers than yes-or-no questions.

Alcohol: "How many days a week do you have a drink, and how many on those days?" The single screening question — "How many times in the past year have you had five or more drinks in a day (four for women)?" — performs well.

Tobacco and nicotine: include vaping and smokeless products explicitly.

Cannabis: frequency, route, and time since last use.

Other substances: ask directly about stimulants, opioids, and sedatives, including non-prescribed use of prescription medication.

Timing matters clinically: "When did you last use?" changes today's anesthetic plan.

SBIRT — Screening, Brief Intervention, and Referral to Treatment — is the standard framework, and dental settings are an evidence-supported place to deliver it.

Oral and Systemic Manifestations by Substance

Substance Oral findings Systemic and management implications

Methamphetamine Rampant cervical and smooth-surface caries ("meth mouth") from xerostomia, bruxism, prolonged high-sugar beverage intake, and neglected hygiene; severe attrition; muscle trismus Avoid vasoconstrictors within ~24 hours of use — risk of hypertensive crisis, arrhythmia, myocardial infarction, stroke. Tachycardia, hypertension, hyperthermia, paranoia, formication

Cocaine Palatal perforation and septal necrosis (intranasal use), gingival ulceration and recession where rubbed on gingiva, bruxism, xerostomia Same 24-hour vasoconstrictor contraindication. Vasospasm, arrhythmia, myocardial infarction even in young patients

Opioids Xerostomia and elevated caries risk, poor hygiene, deferred care Sedation, respiratory depression, constipation; tolerance means standard analgesic doses are inadequate ; withdrawal is uncomfortable but rarely dangerous

Alcohol Erosion from reflux and vomiting, glossitis, angular cheilitis, poor hygiene, elevated oral cancer risk synergistically with tobacco; parotid enlargement (sialosis) Hepatic impairment altering drug metabolism, coagulopathy (reduced clotting factors and thrombocytopenia), gastritis contraindicating NSAIDs, reduce acetaminophen ceiling , drug interactions with sedatives; withdrawal can be life-threatening

Cannabis Xerostomia, leukoedema-like changes, gingival enlargement in some users, elevated caries risk Tachycardia — use epinephrine cautiously in the acutely intoxicated patient ; acute intoxication impairs consent capacity; potentiates sedatives

Tobacco and nicotine Nicotine stomatitis, smoker's melanosis, staining, delayed healing and higher dry socket rates , periodontal destruction, leukoplakia and oral cancer ; smokeless tobacco produces localized keratosis and recession Cessation counseling at every visit; impaired implant and periodontal outcomes

MDMA / club drugs Severe bruxism and attrition, trismus, xerostomia Hyperthermia, hyponatremia, serotonergic interactions

Benzodiazepines and sedatives Xerostomia Additive respiratory depression with nitrous oxide and opioids; withdrawal can cause seizures

Anesthetic and Analgesic Decisions

Vasoconstrictors. The 24-hour rule for cocaine and methamphetamine is one of the most frequently tested facts in this area. Both drugs block catecholamine reuptake or drive catecholamine release; adding exogenous epinephrine risks severe hypertension, dysrhythmia, myocardial infarction, and cerebrovascular accident. If treatment cannot wait, use plain local anesthetic , monitor vital signs, and avoid epinephrine-impregnated retraction cord.

Acute pain management in a patient with opioid use disorder:

Do not interrupt maintenance therapy. Buprenorphine and methadone are continued; stopping them destabilizes recovery and worsens pain control.

Use multimodal non-opioid analgesia — the combination of an NSAID with acetaminophen provides analgesia superior to opioid monotherapy for acute dental pain.

Use long-acting local anesthesia (bupivacaine) for the immediate postoperative period.

Coordinate with the treating provider before prescribing any opioid; if an opioid is genuinely required, expect that tolerance raises the effective dose and prescribe the smallest quantity with close follow-up.

Naloxone co-prescribing should be considered for patients at elevated overdose risk.

Alcohol use disorder: reduce the acetaminophen ceiling (commonly to 2 g per day ), avoid or minimize NSAIDs where gastritis or varices are present, assess coagulation before surgery (PT/INR, platelets), and anticipate altered sedative response — chronic use induces tolerance, but decompensated liver disease produces the opposite.

Safe Opioid Prescribing

Non-opioid first. For acute dental pain, an NSAID alone or combined with acetaminophen is the recommended first-line therapy and is more effective than an opioid alone for most postoperative dental pain.

Definitive treatment beats any prescription. Removing the source of pain — extraction, pulpectomy, drainage — is the analgesic that works.

When an opioid is indicated , prescribe the lowest effective dose for the shortest duration , commonly no more than three days, and avoid extended-release formulations and codeine-containing products in children.

Codeine and tramadol are contraindicated in children under 12 , and in patients under 18 after tonsillectomy or adenoidectomy, because ultra-rapid CYP2D6 metabolizers can experience fatal respiratory depression.

Check the prescription drug monitoring program (PDMP) before prescribing a controlled substance — required in most states.

Never combine an opioid prescription with benzodiazepines or other central nervous system depressants without a compelling reason and explicit counseling.

Counsel on storage and disposal , and document the indication, quantity, and counseling provided.

The Drug-Seeking Encounter

Patterns that should prompt caution: presenting after hours or on a weekend, reporting severe pain with no clinical or radiographic findings, requesting a specific drug by name, reporting allergies to every non-opioid alternative, refusing definitive treatment such as extraction or endodontics, and having no regular dentist.

The correct response is neither hostility nor accommodation:

Perform a complete examination and appropriate radiographs — genuine pathology is sometimes present.

Offer definitive treatment for anything found.

Check the PDMP.

Decline to prescribe an opioid when the clinical findings do not support it, and say so calmly and without accusation.

Offer help — treat the substance use disorder as a medical condition, and provide a referral pathway.

Document findings, the conversation, and the decision.

Referral and Language

Substance use disorder is a chronic, treatable medical condition, not a moral failing. Language shapes care: "a person with a substance use disorder" rather than "an addict," "a person in recovery" rather than "clean," and "positive or negative test result" rather than "dirty." Stigmatizing language measurably reduces the quality of care patients receive and reduces disclosure.

Referral pathways include the patient's primary care provider, addiction medicine specialists, opioid treatment programs, and national treatment-locator services. Offer the referral concretely — a name, a number, and, where possible, a warm handoff — rather than a general suggestion to seek help.